
Author: Joao Lages
Methods to raise capital range from reinvesting operating cash to issuing debt, selling equity or bringing investors into a specific asset. The number of options can make fundraising look like a search for the biggest cheque. In practice, the stronger approach is to build a funding strategy around the company’s use of proceeds, cash-flow profile, risk tolerance and stage of development.
Each source of capital changes the business in a different way. Some create repayment obligations, some transfer ownership, and some depend on narrowly defined eligibility rules. A finance team should therefore compare not only how much capital is available, but also its duration, conditions, governance consequences and cost under realistic scenarios.
The use of funds should determine the funding method. Short-duration working capital, such as inventory or receivables, can often support short-duration finance. Product development, market entry and research have less predictable payback periods, so permanent or patient capital may be more appropriate. Acquisitions and asset purchases may justify a combination of equity and debt when their cash flows and security value can be underwritten.
Management should convert a broad request for money into a milestone plan. Investors and lenders need to know what the capital will fund, when it will be deployed, which measurable outcomes it should produce and what happens if the plan falls behind. This discipline also prevents companies from accepting a convenient instrument that conflicts with the economics of the project.
Capital markets play an important role in connecting savings with productive investment, as the OECD’s capital-markets analysis explains. For an individual issuer, however, access depends on credible disclosure, appropriate structure and a return profile that matches the target investor.
Retained earnings are the least structurally complex source of capital. They do not add a lender, dilute ownership or create a separate securities offering. Businesses can also release cash by improving receivables collection, negotiating supplier terms, reducing excess inventory or disposing of non-core assets.
Internal funding is not free. Cash used for expansion is unavailable for liquidity reserves, dividends, debt reduction or another project. Stretching working capital can also weaken supplier relationships or operational resilience. Finance teams should treat internal cash as capital with an opportunity cost, not as money without a price.
The strongest use of internal capital is often preparatory. It can fund early validation, improve negotiating leverage and demonstrate sponsor commitment before an external raise. That can make later debt or equity more credible without forcing the company to self-finance the entire strategy.
Some businesses can finance growth through customers. Deposits, subscriptions, annual prepayments, milestone billing, pre-orders and long-term offtake agreements can bring cash forward. These structures are most credible when the company has a defined product, reliable delivery capacity and customers willing to commit.
Customer finance aligns funding with demand, but it creates delivery obligations. Revenue collected in advance is not the same as unrestricted cash: the company must still fulfil the contract, manage refunds and recognise revenue correctly. Overreliance on prepayments can also hide weak unit economics if delivery costs arrive later.
Strategic partnerships can provide another commercial route. A distributor, supplier or corporate customer may fund development, guarantee volumes or co-invest in infrastructure. The agreement should define exclusivity, intellectual-property rights, pricing, termination and control over the resulting asset. Capital that limits the company’s future market can be more expensive than it initially appears.
Grants can support research, innovation, regional development, energy transition and other policy objectives. They are attractive because they may be non-dilutive and may not require repayment when conditions are met. Eligibility, permitted expenditure, reporting and audit requirements can nevertheless be demanding.
Companies should not build a liquidity plan around an unapproved grant. Application cycles can be competitive, reimbursement may occur after costs are incurred, and changes to the project can affect eligibility. A grant is best treated as restricted project funding with its own compliance workstream.
Public loan guarantees or subsidised finance may also improve access to debt, but they do not necessarily remove the borrower’s obligations. The precise legal and economic terms matter more than the programme label. Management should verify binding programme documentation and obtain jurisdiction-specific advice.
Debt includes overdrafts, revolving facilities, term loans, equipment finance, receivables finance, private credit and bonds. It lets shareholders retain ownership while the company commits to interest, fees and principal repayment. The suitable instrument depends on the asset being financed and the timing of expected cash generation.
Working-capital facilities should revolve with short-term assets. Equipment finance can amortise over the useful life of machinery. Acquisition or growth debt requires enough operating cash flow to service obligations through a downside case. Maturity, security, covenants, hedging and refinancing risk must be assessed together.
Companies should calculate the all-in cost of debt. Arrangement and commitment fees, legal expenses, mandatory hedging, security packages, prepayment terms and possible warrants can change the economics. A lower coupon does not compensate for a maturity wall the company is unlikely to refinance safely.
Equity provides permanent risk capital in exchange for ownership and negotiated rights. It is often suitable for early-stage companies, ambitious expansion, acquisitions with uncertain integration benefits and projects whose cash flows will take time to mature. Equity can also create balance-sheet capacity for a later debt raise.
The cost is broader than percentage dilution. Preferred returns, liquidation preferences, anti-dilution protections, board rights and vetoes can change control and value distribution. Founders and existing shareholders should model the fully diluted capitalisation table and exit proceeds across multiple scenarios before agreeing terms.
Investor quality matters. Sector knowledge, follow-on capacity and strategic access can be valuable, but only when incentives and time horizons align. A high valuation paired with restrictive rights or unrealistic growth expectations may be less useful than a modestly priced round with supportive governance.
Convertible notes, convertible loans and similar instruments begin with debt-like features but may convert into equity. They can bridge a company to a later priced round, yet they defer rather than eliminate decisions about valuation and dilution. Conversion discounts, valuation caps, maturity, interest and change-of-control treatment need careful modelling.
Asset-specific structures separate a project or pool of assets from the operating company. A special-purpose vehicle may issue debt or equity supported by the economics of real estate, infrastructure, receivables, commodities or another asset. This can clarify cash flows and investor rights, but it adds legal, accounting, governance and servicing requirements.
Tokenisation can provide a digital representation of interests in such a structure and support issuance, ownership records and investor servicing. The token does not replace the underlying legal rights. Issuers still need enforceable documentation, custody and payment arrangements, investor eligibility controls and a clear link between the digital record and the asset.
Crowdfunding can distribute debt or equity offerings to a wider investor base through an authorised channel. It may help companies with a clear public proposition, but it is not simply online marketing. Investor-protection, disclosure, suitability and offering-limit rules vary by jurisdiction and transaction.
In the European Union, the European crowdfunding service-provider framework sets common rules for authorised providers facilitating qualifying business finance. Public securities offerings may instead fall within the EU prospectus regime, subject to exemptions and national rules. Structure, size, instrument and distribution determine the applicable path.
In the United States, offers and sales of securities generally require registration or an available exemption. The SEC staff funding roadmap outlines common routes and their broad characteristics. It is guidance rather than binding law and should not replace transaction-specific legal advice.
A decision matrix prevents teams from choosing on headline price alone. Score each credible method against the same criteria:
The company should then model a blended capital stack. Internal cash can establish proof, equity can absorb early uncertainty, and debt can fund predictable assets once cash flows are visible. Sequencing matters because each round changes the risk and bargaining position for the next one.
A deeper comparison of debt and equity capital helps clarify the two principal external routes. Companies intent on preserving ownership can also review non-dilutive funding strategies, while recognising their contractual and operational costs.
The correct provider depends on the selected method, investor base and jurisdiction. Relevant options include:
Provider selection should follow instrument selection, not substitute for it. Technology and distribution can improve execution, but they cannot repair a weak investment case, ambiguous legal rights or an unsustainable capital structure.
A fundraising process needs reconciled historical information, an integrated financial model, a detailed use-of-proceeds plan and an organised diligence room. The model should show how the new capital changes revenue capacity, cost structure, liquidity and future financing needs. Assumptions should be traceable to operating evidence or clearly identified as estimates.
Management should define a target structure and an acceptable range. This includes the amount, instrument, maturity or ownership offered, governance rights and conditions that would make the transaction unattractive. Negotiating these boundaries internally before outreach reduces the risk of accepting capital that solves an immediate cash problem while weakening the long-term business.
Methods to Raise Capital: A Comprehensive Guide to Funding Strategies is ultimately a question of fit. Internal cash, customer finance, grants, debt, equity, hybrid instruments and asset-specific offerings each solve different problems. No method is universally cheapest once risk, control, duration and execution are included.
The strongest funding strategy often combines sources in a deliberate sequence. It funds uncertainty with resilient capital, uses contractual finance where repayment is visible and preserves enough flexibility for the next stage. Capital should extend strategic capacity, not merely postpone a liquidity constraint.
If you are considering launching a tokenised investment product, speak with Lympid.